| OBSERVATION'S |
The fraction of the API market devoted to high-potency compounds is still small--less than 5%. "It's a niche," he says. Co. just built the Co.`s Advanced Synthesis development and manufacturing facility in Biasca, Switzerland. This high-potency plant will produce both Co.`s own antiemetic drug, as well as compounds for its outsourcing partners. |
| UPDATE | 04.01 |
| COMPANY | This data is not available for free |
| CONTACT | This data is not available for free |
| LITERATURE REF. | This data is not available for free |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |